While a win for consumers, the regulatory action did nothing to stem the manufacture of compounded versions of the popular ...

Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and ...

The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like ...

The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that ...

Agency warns of multiple concerns related to unapproved compounded drugs, including semaglutide and tirzepatide.

The Food and Drug Administration has created a new “green list” import alert to stop potentially unsafe GLP-1 drug ingredients, including semaglutide and tirzepatide, from entering the U.S. from ...

FDA introduces a green list to block unsafe GLP-1 drug imports, while WHO updates its essential medicines list to include ...

The US Food and Drug Administration has made a 'green list' import alert to stop unapproved and unauthorised glucagon-like ...

The FDA has accepted a new drug application for relacorilant as a treatment for patients with platinum-resistant ovarian ...

WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on ...

April 17, 2012 — The US Food and Drug Administration (FDA) today issued its latest quarterly list of drugs to monitor after having identified potential signs of serious risks or new safety information ...